235 related articles for article (PubMed ID: 24743732)
1. Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death.
Chen H; Huang S; Han X; Zhang J; Shan C; Tsang YH; Ma HT; Poon RY
Cell Death Dis; 2014 Apr; 5(4):e1177. PubMed ID: 24743732
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Chin GM; Herbst R
Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
[TBL] [Abstract][Full Text] [Related]
4. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
5. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.
Huang HC; Shi J; Orth JD; Mitchison TJ
Cancer Cell; 2009 Oct; 16(4):347-58. PubMed ID: 19800579
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents.
Wysong DR; Chakravarty A; Hoar K; Ecsedy JA
Cell Cycle; 2009 Mar; 8(6):876-88. PubMed ID: 19221504
[TBL] [Abstract][Full Text] [Related]
7. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis.
Kollareddy M; Sherrard A; Park JH; Szemes M; Gallacher K; Melegh Z; Oltean S; Michaelis M; Cinatl J; Kaidi A; Malik K
Cancer Lett; 2017 Sep; 403():74-85. PubMed ID: 28602975
[TBL] [Abstract][Full Text] [Related]
8. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
[TBL] [Abstract][Full Text] [Related]
9. Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.
Salmela AL; Pouwels J; Varis A; Kukkonen AM; Toivonen P; Halonen PK; Perälä M; Kallioniemi O; Gorbsky GJ; Kallio MJ
Carcinogenesis; 2009 Jun; 30(6):1032-40. PubMed ID: 19395653
[TBL] [Abstract][Full Text] [Related]
10. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.
Mäki-Jouppila JH; Laine LJ; Rehnberg J; Narvi E; Tiikkainen P; Hukasova E; Halonen P; Lindqvist A; Kallio L; Poso A; Kallio MJ
Mol Cancer Ther; 2014 May; 13(5):1054-66. PubMed ID: 24748653
[TBL] [Abstract][Full Text] [Related]
11. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
Kaestner P; Stolz A; Bastians H
Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-dependent cytotoxicity and mitotic spindle checkpoint dependency of investigational and approved antimitotic agents.
Birk M; Bürkle A; Pekari K; Maier T; Schmidt M
Int J Cancer; 2012 Feb; 130(4):798-807. PubMed ID: 21387302
[TBL] [Abstract][Full Text] [Related]
13. SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest.
Inoue T; Nakayama Y; Yamada H; Li YC; Yamaguchi S; Osaki M; Kurimasa A; Hiratsuka M; Katoh M; Oshimura M
Cell Cycle; 2009 Apr; 8(8):1279-91. PubMed ID: 19282667
[TBL] [Abstract][Full Text] [Related]
14. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
Scaife RM
Mol Cancer Ther; 2004 Oct; 3(10):1229-37. PubMed ID: 15486190
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons.
Yamada HY; Gorbsky GJ
Mol Cancer Ther; 2006 Jan; 5(1):29-38. PubMed ID: 16432160
[TBL] [Abstract][Full Text] [Related]
16. PCTAIRE1 promotes mitotic progression and resistance against antimitotic and apoptotic signals.
Gillani SQ; Reshi I; Nabi N; Un Nisa M; Sarwar Z; Bhat S; Roberts TM; Higgins JMG; Andrabi S
J Cell Sci; 2022 Feb; 135(3):. PubMed ID: 35044463
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
18. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
[TBL] [Abstract][Full Text] [Related]
19. A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling.
Draviam VM; Stegmeier F; Nalepa G; Sowa ME; Chen J; Liang A; Hannon GJ; Sorger PK; Harper JW; Elledge SJ
Nat Cell Biol; 2007 May; 9(5):556-64. PubMed ID: 17417629
[TBL] [Abstract][Full Text] [Related]
20. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
